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Focal segmental glomerular sclerosis: The cellular lesion. The patho-
logical features of 59 renal biopsy specimens with focal segmental
glomerular sclerosis (FSG) were correlated with the patient's clinical
and laboratory findings at the time of biopsy. Two morphologic patterns
were identified: thirty-nine biopsy specimens had only focal segmental
scars which were frequently associated with hyaline deposits. In 20
biopsy specimens with FSG, the glomeruli also contained a cellular
lesion. It consisted of hypercellularity in the involved portion of the
glomerulus, increased cells in the surrounding Bowman's space, and
reactive and proliferative changes in the associated glomerular visceral
epitheial cells. The cellular lesion was seen overlying glomerular
capillaries with minimal histologic abnormalities and adjacent to scars.
However, it was usually superimposed upon a segmental scar or a
portion of the glomerulus with collapsed capillaries and wrinkled,
folded basement membranes. Immunofluorescence and electron mi-
croscopy did not demonstrate significant immune reactants or electron-
dense deposits in the glomeruli. Nineteen of 39 patients with only
segmental scars had proteinuria equal to or greater than 3.0 g/day, and
nine had the nephrotic syndrome. Eighteen of 20 patients with the
cellular lesion had proteinuria equal to or greater than 3.0 g/day, and 14
had the nephrotic syndrome. The interval between the onset of protein-
uria and biopsy was much shorter in patients with the cellular lesion (3.4
3 vs. 71.9 87 months, mean Sn, P < 0.01). This difference was
also significant when only those with nephrotic range proteinuria were
compared (3.4 3 vs. 45.6 73 months, mean SD, P < 0.01).
Patients with FSG, with or without the cellular lesion, were similar with
respect to male/female ratio, age, serum creatinine, and diastolic blood
pressure. From these observations, we believe that glomerular injury,
evidenced by segmental proliferative lesions with signs of epithelial cell
injury, is a significant factor in the pathogenesis of FSG. The temporal
relationship between the cellular lesion and the onset of clinical
manifestations of the nephrotic syndrome suggests that these pathologic
changes are not merely secondary to chronic proteinuria and may
represent specific damage to the etiologic insult.
Hyalinose segmentaire et focale: Ia lesion ceflulaire. Les
caractéristiques anatomopathologiques de 59 examens histologiques
rénaux avec une hyalinose segmentaire et focale (HSF) ont Cté
corrélées avec les données cliniques et biologiques des malades au
moment de Ia biopsie. Deux aspects morphologiques ont etC identifies:
39 prClèvements avaient seulement des cicatrices focales et
segmentaires qui Ctaient frequemment associCes avec des dCpôts
hyalins. Dans 20 specimens avec une HSF, les glomCrules contenaient
egalement une lesion cellulaire. Celle-ci consistait en une
hypercellularitC de la portion atteinte du glomCrule, en une
hypercellularitC sous-jacente dans l'espace de Bowman, et en des
modifications prolifCratives et rCactionnelles des cellules epithCliales
glomerulaires en regard. La lesion cellulaire a etC observCe au dessus de
capillaires glomCrulaires n'ayant que des anamolies histologique
minimes et adjacents aux cicatrices. Cependant die Ctait le plus souvent
surajoutCe a une cicatrice segmentaire ou a une portion de glomCrule
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ayant des capillaires rCtractCs et des membranes basales plissCes et
chiffonCes. La microscopic optique et l'examen en immunofluorescence
n'ont pas montrC de dCpôts denses aux Clectron ou fixant les im-
munsCrum dans les glomCrules. 19 patients sur 39 n'ayant que des
cicatrices segmentaires avaient un protCinurie superieure ou Cgale a 3 g
par jour, et 9 avaient un syndrome nephrotique. 18 patients sur 20 ayant
la lesion cellulaire avaient une protCinurie supCrieure ou egale a 3 g par
jour et 14 avaient un syndrome nephrotique. L'intervalle entre l'ap-
parition de la protCinurie et Ia biopsie Ctait beaucoup plus court chez les
patients ayant la lesion cellulaire (3,4 3 contre 71,9 87 mois,
moyenne SD, P < 0,01). Cette difference était egalement significative
quand on ne comparait que les patients ayant un syndrome nephrotique
(3,4 3 contre 45,6 73 mois, moyenne SD, P < 0,01). Les patients
ayant une HSF avec ou sans Ia lesion cellulaire Ctaient comparables en
cc qui concerne Ic sex-ratio, l'age, Ia crCatininémie, et Ia pression
artCrielle diastolique. A partir de ces observations, nous pensons que
l'atteinte glombrulaire, dCmontrCe par des lesions proliferatives
segmentalres avec des signes d'atteinte de Ia cellule Cpitheliale, est on
ClCment significatif dans Ia pathogenic de la HSF. La relation
temporelle entre Ia lesion cellulaire et le debut des manifestations
clinique de syndrome nCphrotique suggere que ces modifications
anatomopathologiques ne sont pas seulement secondaires a Ia
protCinurie chronique mais peuvent reprCsenter une lesion specifique
dUe l'agression causale.
Focal segmental glomerular sclerosis (FSG) is a pathologic
diagnosis that describes a distribution of glomerular scarring
without reference to etiology or pathogenesis. It is the morpho-
logic expression of many pathologic processes, and it occurs in
a primary form unassociated with antecedent glomerular or
systemic diseases. When primary FSG is seen in a patient with
the nephrotic syndrome, it has important prognostic implica-
tions because it identifies a group of children and adults with a
poor response to steroid therapy who frequently develop pro-
gressive deterioration of renal function [1—10].
The morphologic sine qua non of FSG is a segmental glomer-
ular scar, but other pathologic features have been associated
with the diagnosis [11]. The pathogenetic and prognostic signif-
icance of these features, separate from that of glomerular scars,
is unknown. Epithelial cell injury has been implicated in the
pathogenesis of FSG by previous morphologic studies. Epithe-
hal cell proliferation and hypertrophy have been described [9,
11—151. More serious signs of epithelial injury may be present
and include focal separation from the basal lamina and necrosis
[12, 16]. Diffuse epithelial cell foot process effacement has been
reported, not only in the glomeruli which contain scars, but also
in the glomeruli which appear otherwise normal [11].
In the present study, we evaluate biopsy specimens from
patients with FSG for several morphologic parameters, includ-
ing evidence of epithelial cell injury and proliferation. We
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correlate the various pathologic features with the historical
onset of proteinuria and/or the nephrotic syndrome and clinical
and laboratory features present at the time of biopsy. Our
purpose is to study whether a cellular lesion can be identified
during the course of FSG. The presence of such a lesion has
obvious implications with respect to the pathogenetic process
involved in the development of FSG.
Methods
Patient selection
In review of the 1,330 renal biopsies in our renal pathology
files at Rush-Presbyterian-St. Luke's Medical Center, Chicago,
Illinois between July, 1975, and April, 1984, we selected all
patients who had pathologic diagnoses that included focal
glomerulonephritis, focal segmental glomerulonephritis, focal
segmental glomerular sclerosis, segmental glomerulonephritis,
segmental glomerular sclerosis, and focal segmental glomerular
sclerosis and hyalinosis. In addition, patients with the diagnosis
of lipoid nephrosis (minimal change glomerulonephropathy)
were also studied as a control for the effect of proteinuria per se
upon glomerular epithelial cell proliferation.
The patients' clinical records were reviewed for evidence of
systemic diseases and renal diseases that may be associated
with glomerular pathology, and these patients were excluded
from further analysis. The following clinical data at the time of
biopsy were noted: diastolic blood pressure, 24-hr urinary
protein excretion, age, sex, serum creatinine, and interval from
the clinical onset of proteinuria to the renal biopsy. The
diagnosis of the nephrotic syndrome was a clinical judgment
based on the presence of proteinuria equal to or greater than 3.0
g/day, edema, hypoalbuminemia, and hypercholesterolemia.
Renal tissue obtained at biopsy was divided and processed
for light, fluorescence, and electron microscopy [171. In each
case, slides stained with hematoxylin and eosin, Masson
trichrome, periodic acid Schiff (PAS), and methenamine silver
periodic acid Schiff (Jones) were available for review. The
histologic evaluation of this material was made by one person
(MMS), who did not have access to the clinical data related to
the case. Clinical data, including the presence of the nephrotic
syndrome, the quantity of proteinuria, or the duration of
symptoms, was made available only after the histologic evalu-
ation was complete. Histological features recorded included the
total number of glomeruli, the number of glomeruli with global
scars, the number of glomeruli with focal segmental scars, and
the number of glomeruli with the cellular lesion (see below).
Mesangial hypercellularity was diagnosed when the number of
mesangial cells was equal to or greater than three per mesangial
area.
Fluorescence results were reviewed by studying photomicro-
graphs of positively stained glomeruli and the detailed reports
written at the time of the initial study. We specifically recorded
the number of glomeruli studied and the number of glomeruli
stained with 1gM and the third component of complement (C3).
Separately recorded were mesangial (diffuse or segmental)
deposits and segmental deposits that were confined to a scarred
area. The strength of the staining was semiquantitated using an
arbitrary scale from zero to four plus.
Review of electron microscopy was achieved by study of
electron micrographs and the initial report. In each case we
noted the number of glomeruli sectioned, the presence and
location of electron-dense deposits, and the presence of diffuse
or focal foot process effacement. The extent of foot process
effacement was estimated from examination of the glomerulus
with the electron microscope, and it was confirmed on the
photographs of the specimen. Diffuse foot process effacement
was defined as involvement of more than 75% of the surface
area of the glomerular capillaries.
Tabulation of the segmental scars and active lesions in focal
segmental glomerular sclerosis
The diagnosis of primary focal segmental glomerular sclerosis
(FSG) was established on the criteria defined by the Inter-
national Study of Kidney Disease in Children as reported by
Churg, Habib, and White [2]. Patients with clinical evidence of
systemic disease with renal involvement or known primary
glomerular diseases were excluded from the analysis. This
morphologic diagnosis was made without regard to the level of
protein excretion. Eligible for this study were biopsy specimens
in which the glomerular lesion was focal (not all glomeruli
involved) and segmental (involved glomeruli only partially
involved) and consisted of scarring and collapse of part of the
glomeruli tuft, with or without hyaline exudates and adhesions
between the tuft and Bowman's capsule. In addition, some
cases of FSG had a cellular glomerular lesion (see below).
We divided cases of FSG into two categories. One had only
segmental glomerular scars, which frequently included hyaline
deposits. The second category of FSG included the presence of
a cellular lesion in the glomeruli (see Results). Cellular lesions
were seen in Bowman's space overlying glomerular capillaries
with mild histologic abnormalities and adjacent to segmental
glomerular scars. However, the cellular lesion was usually
superimposed upon a segmental scar or a portion of the
glomerulus with collapsed capillaries and wrinkled, folded
basement membranes.
Results
Pathology of primary FSG
In a series of 1,330 renal biopsies, almost exclusively in
adults, there were 37 cases of FSG in patients with 24-hr urinary
protein excretion equal to or greater than 3.0 g, and 22 cases in
patients with less than 3.0 g urinary protein excretion per day.
In addition, there were 51 cases of lipoid nephrosis and 174
cases of glomerulonephritis associated with systemic disease in
which segmental scarring with or without proliferation was a
prominent histologic feature (Table 1).
In 59 patients with FSG, 39 had only segmental scars and 20
had cellular lesions. The prevalence of glomerular involvement
in biopsy specimens with only segmental scars ranged from 3 to
57% with a mean of 19 9 (± SD). The basic lesion among these
39 biopsies was a focal segmental glomerular scar (Fig. 1).
Other histologic features included collapsed capillaries (Fig. 2)
and hyaline, PAS-positive exudates within the collapsed ioops
and within adhesions between the involved portion of the tuft
and Bowman's capsule (Fig. 3). Occasional foamy macrophages
were present in the collapsed capillaries. No examples of
diffuse mesangial hypercellularity ( 3 cells/mesangial area)
were seen. In 73% of the cases, the glomeruli with segmental
scars were associated with some completely hyalinized
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Table 1. Incidence of focal segmental glomerulonephritis in a series
of 1,330 renal biopsies
Primary focal segmental glomerular sclerosis 59 (45)a
Urinary protein excretion:
3.Og/24hr 37
<3.0 g/24 hr 22
Lipoid nephrosis 51 (3.9)
Segmental glomerulonephritis of known etiology 174 (13)
Systemic lupus erythematosus 73
Microscopic polyarteritis 37
IgA nephropathy 34
Wegener's granulomatosus 11
Membranous glomerulonephritis 6
Others 13
a Percentage of total biopsy specimens.
Fig. 1. Focal segmental glomerular sclerosis. The glomerulus on the
right has a broad adhesion between the tuft and Bowman's capsule. The
uninvolved portion of the glomerulus and the glomerulus on the left are
normal in appearance. (Jones, X200)
Fig. 2. Segmental glomerular scar. The involved portion of the
glomerulus has collapsed capillaries which are obliterated by scar
tissue. (Jones, X300)
glomeruli (global sclerosis). Global glomeru1a sclerosis in-
volved from 3 to 60% of the glomeruli in the biopsy specimens
in which it was present, with a mean of 20 22% (± sD). The
uninvolved glomeruli and the unscarred portions of the in-
volved glomeruli were essentially within normal limits with
thin, delicate basement membranes and normal mesangial
cellularity and matrix.
Twenty of 59 patients with FSG had the cellular lesion in their
glomeruli. The prevalence of glomerular involvement with the
cellular lesion ranged from 5 to 44%, with a mean of 19 13%
(± SD). The relationship between the cellular lesion and seg-
mental glomerular scars was variable. In some glomeruli, the
cellular lesion involved a glomerular segment with minimal
underlying glomerular abnormalities. In other instances, the
cellular lesion was concomitant with segmental scars which
involved other portions of the same glomerulus or other
glomeruli. The cellular lesion was associated with segmental
glomerular scars in other glomeruli in 11 out of 20 cases, and
when present, isolated segmental scars involved from 5 to 20%
of the glomeruli (9 5%, mean SD). However, most
examples of the cellular lesion were superimposed upon either
a segmental scar or a portion of the glomerulus with shrunken
collapsed capillaries and thickened, wrinkled basement mem-
Fig. 3. Segmental glomerular sclerosis and hyalinosis. The segmental
glomerular scar has hyaline eosinophilic deposits in the collapsed
capillaries (*) and in the adhesion between the tuft and Bowman's
capsule (arrow). (H&E, x300)
branes. The cellular lesions contained an increased number of
cells in Bowman's space which were either localized to the
involved segment (Fig. 4) or involved the entire glomerulus
(Fig. 5). The cellular lesion in Bowman's space included prolif-
erating epithelial cells evidenced by occasional mitoses (Fig. 6).
The possible inclusion of macrophages in this lesion was not
assessed. In addition, segmental mesangial hypercellularity
(Fig. 7), foam cells, and polymorphonuclear leukocytes and
karyorrhectic debris (Fig. 8) contributed to the cellularity of the
lesion. The involved epithelial cells had enlarged vesicular
nuclei with prominent nucleoli (Fig. 9). The cytoplasm was
abundant and frequently basophilic. In some instances, the
cytoplasm was vacuolated and contained numerous, PAS-
positive droplets (Fig. 10). The uninvolved segments were
normal in most cases, but mesangial hypercellularity ( 3
cells/mesangial area) was seen in four biopsy specimens. Global
sclerosis was seen in only seven of 20 cases with cellular
lesions. When it was present, global sclerosis involved from 13
to 73% of the glomeruli, with a mean of 50 27% (± SD).
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Fig. 4. FSG, cellular lesion. Increased cells in Bowman's space
(arrows) are associated with a solidified hypercellular segment in the
glomerulus. (H&E, x300)
Fig. 5. FSG, cellular lesion. Increased cellularity and reactive changes
in the epithelial cells are seen throughout Bowman's space. The
glomerulus has diffuse collapse of the capillaries, many of which are
occluded by macrophages. (Jones, x300)
Fluorescence microscopy was performed on 57% of the
biopsy specimens with only segmental scars and 90% of those
with the cellular lesion (Table 2). There were segmental depos-
its of 1gM in sclerotic segments of the glomerulus in 50% of the
specimens with segmental scars and 61% of those with the
cellular lesion that were examined. Other immunoglobulins,
complement components, and serum proteins were incon-
stantly noted in FSG, with and without the cellular lesions.
Mesangial deposits of 1gM were present in 42% of the speci-
mens with segmental scars and 22% of those with the cellular
lesions. These mesangial deposits were segmental and weakly
stained in most instances. However, an occasional biopsy
specimen did have a more prominent mesangial deposition
pattern for 1gM. Glomerular deposits of C3 were present in 39%
of specimens with segmental scars and 50% of the cases with
the cellular lesion. They followed the segmental distribution
of 1gM in the tissue. With the exception of mesangial 1gM,
the uninvolved glomeruli contained no significant immune
reactants.
Fig. 6. FSG, cellular lesion. Extracapillary hypercellularity (arrows)
associated with a mitosis. (H&E, x500)
Fig. 7. FSG, cellular lesion. The involved portion of the glomerulus
shows mesangial proliferation, extracapillary hypercellularity, reactive
changes in the epithelial cells and foam cells (*). The uninvolved
segment appears normal (arrow), (H&E, x300)
Glomerular ultrastructure was evaluated in 77% of the spec-
imens with segmental scars and 90% of the cases with the
cellular lesion. Segmental scars or cellular lesions were present
on the ultrathin sections in one-third of the cases. The features
seen in FSG with and without the cellular lesion were similar,
with the exception of epithelial cell pathology. Biopsy speci-
mens with the cellular lesion had active-appearing glomerular
visceral epithelial cells. In contrast, the epithelial cells overly-
ing segmental scars were simplified, with foot process efface-
ment and condensed cytoplasm. Separation of the epithelial
cells from the basal lamina and lysis of the cytoplasm were
rarely seen. Foot process effacement was variable, with some
specimens showing focal and others showing diffuse changes in
the epithelial cells in the portions of the glomerulus uninvolved
by segmental lesions. The degree of foot process effacement
appeared to correlate with the amount of urinary protein
excretion rather than the presence or absence of the cellular
lesion (Table 3).
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Fig. 8. Karyorrhectic debris is present within a hypercellular glomerular Fig. 10. Hypertrophied epithelial cells contain numerous absorption
lobule. Capillary basement membrane (arrows). Bowman's capsule (*) droplets. The underlying capillaries are patent. (H&E, x500)
(H&E, x500)
Table 2. Fluorescence microscopy in FSG
Fig. 9. The glomerular epithelial cells in the active lesion have copious,
frequently basophilic cytoplasm, cytoplasmic inclusions (arrow), and
enlarged nuclei with prominent nucleoi. The underlying glomerulus
shows minimal histologic abnormalities. (H&E, X500)
Clinical features of patients with FSG at the time of biopsy
(Table 4)
Nineteen of the 39 patients with only segmental glomerular
scars had proteinuria equal to or greater than 3.0 g/24 hr. Only
nine of these patients had the nephrotic syndrome. Among the
20 patients with FSG and the cellular lesion, 18 had proteinuria,
equal to or greater than 3.0 g124 hr, and 14 had the nephrotic
syndrome (Fig. 11). Patients with FSG with and without the
cellular lesion were similar with respect to the male/female
ratio, age, serum creatinine, and diastolic blood pressure. Less
than 3.0 g proteinuria per 24 hr was seen in 20 patients with
segmental scars, but only two patients with the cellular lesion
had less than 3.0 g proteinuria. When only patients with
proteinuria equal to or greater than 3.0 g124 hr were considered,
there was no difference in protein excretion between patients
with FSG with and without the cellular lesion (7.0 5 vs. 9.5
5 g/day, mean SD).
Focal segmental glomerular sclerosis
Cases with segmental Cases with
scars only cellular lesions
(N=23) (N= 18)
Glomerular 1gM
Segmental ll 11
Diffuse mesangial 8 4
Glomerular C3 9 9
a Number of cases positive.
Table 3. Electron microscopy in FSGa
Focal segmental glomerular sclerosis
Cases with segmental Cases with cellular
scars only lesions
3.0 glday <3.0 glday 3.0 glday <3.0 glday
Total cases 13 15 17 1
Normal foot 2 2 1 1
processes (14%) (12%) (8%) (100%)
Focal foot process 2 11 2 —
effacement (14%) (76%) (12%)
Diffuse foot 9 2 14 —
process (64%) (12%) (82%)
effacement
a Values are the level of protein excretion.
The interval between the onset of proteinuria and biopsy in
those with the cellular lesion ranged from 1 week to 5 months
(3.4 3 months, mean SD) while those who had only
segmental scars had a prebiopsy interval which ranged from 1
week to 288 months (71.9 87 months, mean SD, P < 0.01).
When only patients with proteinuria equal to or greater than 3.0
g/24 hr were considered, the interval from onset of symptoms to
biopsy was still significantly longer in those with only segmental
scars (45.6 73 months) than in those with the cellular lesions
(3.4 3 months, P < 0.01). Thirteen patients with segmental
scars had a history of proteinuria for 8 months or less, while 21
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Cases with
segmental
scars only
Cases with
cellular
lesions
Number of patients 39 20
Patients with protein-
uria, 3 glday 19 P < 0.005 18
Patients with the ne-
phrotic syndrome 9 P < 0.005 14
MIF ratio 30/9 NS 12/8
Age, years 41 16 NS 36 14
Time between onset of
proteinuria and bi-
opsy, months 71.9 87 F <0.01 3.4 3
Serum creatinine,
mg/dl 1.8 1.5 NS 2.3 1.8
Diastolic blood pres-
sure, mm Hg 94 24 NS 85 12
24-hr urinary protein
excretion, g/24 hr 4.4 4 P < 0.01 8.5 5
Focal segmental glomerular sclerosis
Cases with Cases with
Interval segmental scars only cellular lesions
<8 months 13 19
8 months 25 1
had more than 8 months of proteinuria. In contrast, 19 of 20
patients with segmental scars and the cellular lesion had 8
months or less of proteinuria (Table 5, P < 0.00 1).
Clinicopathological features in patients with lipoid nephrosis
In this series, there were 47 patients with lipoid nephrosis
who had a total of 51 biopsies. Reflecting the clinical charac-
teristics of our experience, 41 of the patients were adults and
seven were children (16 years old or less). There were 16 males
and 31 females. The mean age of the patients with lipoid
nephrosis (37 21 years) was similar to that of the patients with
focal glomerular sclerosis (39 15 years, P > 0.05). Lipoid
nephrosis was diagnosed in patients with the nephrotic syn-
drome whose glomeruli were normal by light microscopy. Signs
of glomerular proliferation and glomerular epithelial cell pathol-
ogy were specifically sought, and they also were not present. In
thirteen biopsy specimens lipoid nephrosis was associated with
global sclerosis, and when present, global sclerosis involved a
mean of 10 6% (± SD) of the glomeruli. Patients were not
excluded from this category by the presence of global glomer-
ular sclerosis. Daily urinary protein excretion in patients with
lipoid nephrosis (10.0 8 g) (± SD) was compared to patients
with nephrotic range proteinuria with FSG with (8.5 5 g) (P <
0.05, SD) and without cellular lesions (4.4 4 g) (P > 0.05).
Discussion
The biopsy specimens of some patients with the idiopathic
nephrotic syndrome have a readily identifiable glomerular le-
sion characterized by segmental proliferation, hypercellularity
in Bowman's space, and reactive changes in the glomerular
visceral epithelial cells. In patients with nephrotic syndrome,
the relationship between this proliferative and degenerative
lesion and segmental glomerular scars may be of central impor-
tance because of the pathogenetic implications regarding the
process of glomerular scarring and progressive renal disease.
Scars are generally considered to be the end result of an
antecedent glomerular injury. Since they are non-specific, they
tell us nothing about the process that led to their formation [18].
The presence of segmental scars in conjunction with the his-
tologic evidence of glomerular epithelial cell injury implies the
possibility that the proliferative lesion may result in the ultimate
formation of glomerular scars. In the material that was studied,
the presence of epithelial cell pathology in biopsy specimens
taken soon after the onset of symptoms secondary to protein-
uria and its correlation with the nephrotic state suggest that it is
a morphologic manifestation of a primary glomerular disease.
The absence of these epithelial cell changes in patients with
massive proteinuria due to lipoid nephrosis implies that they are
not merely the result of increased filtration of plasma proteins.
These observations lead us to suggest that initial glomerular
injury characterized by hypercellularity in Bowman's space and
reactive changes in the glomerular epithelial cells initiates a
pathogenetic sequence which culminates in the formation of
segmental scars, and, as such, these changes constitute the
early lesion of FSG.
The relationship between cellular lesions and segmental
glomerular scars in patients with the idiopathic nephrotic syn-
drome is the central issue we address in this paper. We have
interpreted our data to imply a pathogenetic sequence between
cellular glomerular lesions and segmental scars, but we recog-
nize that other possibilities exist. Both lesions may be caused
by the same mechanism, but rather than the cellular lesion
preceeding the scar and healing to form a scar, both lesions may
be formed simultaneously. In this case, when the cellular
lesions heal, only the scars persist. The scars and the cellular
lesions may also represent a spectrum of injury, with scars
occurring only in the more severely damaged glomeruli. In
contrast, the cellular lesions and segmental scars may be caused
by unrelated mechanisms, and their common clinical presenta-
tions may result from the limited range of the glomerular
response to injury. At the present time, we do not have the
necessary information to decide among these alternatives, but
recognition that the cellular lesion is a significant feature of the
Table 4. Clinical features at the time of biopsy in patients with focal
segmental glomerular sclerosis
Mean 5D.
Abbreviation: NS, not significantly different.
Focal segmental glomerular sclerosis (59)
Only segmental
glomerular scars (39) Segmental glomerularscars and cellular lesions (20)
Proteinuria Proteinuria/\ /\
3.0 g/day < 3.0 g/day > 3.0 g/day < 30 g/day
(19) (20) (18) (2)
Fig. 11. Prevalence of segmental and cellular lesions in FSG. Number
of patients in parentheses.
Table 5. Interval from onset of proteinuria to renal biopsy in FSG
= 33.75.
F <0.001.
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idiopathic nephrotic syndrome and that it is temporally related
to the onset of massive proteinuria may provide insight into the
pathogenesis of this enigmatic form of glomerular disease.
A proliferative and reactive epithelial cell component has
been previously described in FSG, and other reports have also
implied this lesion to be a significant finding [9, 12, 14, 15]. In
three series where it was quantitated, epithelial cell pathology
was present in 48 [91, 63 [12], and 18% [14] of biopsy specimens
with FSG. In a series of 16 adults with FSG, Grishman and
Churg [12] illustrated the cellular lesion, and they found epithe-
hal cell proliferation in seven of 11 patients with a duration of
disease of 1 year or less. In that series, only one of five patients
with more than a 1-year history had a similar degree of epithelial
pathology. This association between the onset of symptoms and
the histologic finding, which they reported but did not discuss,
is statistically significant and is in agreement with the results
that we report, Conceivably, biopsy specimens with the cellular
lesion have been diagnosed as focal proliferative glomerulone-
phritis [19]. Thus, the lesion we have identified as a component
of FSG must be distinguished from the many forms of glomer-
ulonephritis that manifest a focal segmental glomerulonephritis
on renal biopsy [20]. Although the histological appearance of
the cellular lesion of FSG is not diagnostic by light microscopy,
it should not be confused with other lesions described as focal
glomerulonephritis when all the morphological and clinical
features are considered.
Our findings imply that the glomerular abnormalities found in
FSG are not limited to segmental glomerular scars, but include
evidence of glomerular epithelial cell injury and proliferation.
The relationship between the duration of the nephrotic syn-
drome and morphologic signs of epithehial cell injury implies
that these lesions may be involved in the development of
segmental scars. This mechanism is further supported by the
frequent occurrence of cellular lesions and segmental scars.
Most of the cellular lesions are superimposed upon segmental
scars, and they frequently occur in biopsy specimens that
contain segmental scars in other glomeruli. In the absence of
consistent morphologic alterations of the glomerular mesan-
gium, our results suggest that the pathogenetic process that
culminates in the segmental scar of FSG may begin as epithelial
cell damage. However, the mechanism of epithelial cell damage
is a matter of conjecture. It is tempting to postulate the
existence of a toxic factor, perhaps of lymphoid cell origin,
which may be responsible for altered epithelial cell function and
may ultimately lead to epithelial cell damage, proliferation, and
cell death. The failure of epithelial cells to maintain normal
capillary wall function may ultimately lead to segmental col-
lapse of the capillary tuft and scarring. On the basis of the
consistent finding of abnormal visceral epithelial cell morphol-
ogy early in the course of FSG with the nephrotic syndrome, we
suggest this to be a clue to the pathogenesis of the sclerotic
lesion.
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